Abstract Background Aberrant Wnt/β-catenin signaling is associated with breast cancer even though genetic mutations in Wnt signaling components are rare. We have previously demonstrated that Rad6B, an ubiquitin conjugating enzyme, stabilizes β-catenin via polyubiqutin modifications that render β-catenin insensitive to proteasomal degradation. Rad6B is a transcriptional target of β-catenin, creating a positive feedback loop between Rad6B expression and β-catenin activation. Methods To isolate subpopulations expressing high or low Rad6B levels, we transfected MDA-MB-231 or WS-15 human breast cancer cells with ZsGreen fluorescent reporter vector in which the expression of ZsGreen was placed under the control of Rad6B promoter. ZsGreenhigh and ...
Ubiquitin-specific protease 6 (USP6) is a deubiquitylase that is overexpressed by chromosome translo...
AbstractThe present study investigated the roles of E6 and E6AP in the Wnt pathway. We showed that E...
Prognosis for patients with estrogen-receptor (ER)-negative basal breast cancer is poor, and chemoth...
AbstractThe ubiquitin conjugating enzyme Rad6B is overexpressed in breast cancer and induces β-caten...
AbstractAutocrine Wnt signaling in the mouse mammary tumor virus model was the first identified mech...
Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation, proli...
Human breast cancer displays nuclear accumulation of β-catenin and induction of cyclin D1 expression...
Our previous data illustrated that activation of the canonical Wnt signaling pathway was enriched in...
We have previously shown that the postreplication DNA repair gene Rad6B plays a critical role in the...
SummaryThe Wnt/β-catenin signaling pathway plays a major role in tissue homeostasis, and its dysregu...
AbstractMelanoma is the leading cause of death from skin cancer in industrialized countries. Several...
SummaryCanonical Wnt signaling critically regulates cell fate and proliferation in development and d...
AbstractMany cancers have similar aberrations in various signaling cascades with crucial roles in ce...
The development of skeletal muscle from immature precursors is partially driven by canonical WNT/β-c...
We have been investigating a novel link between two independent processes linked to breast cancer: W...
Ubiquitin-specific protease 6 (USP6) is a deubiquitylase that is overexpressed by chromosome translo...
AbstractThe present study investigated the roles of E6 and E6AP in the Wnt pathway. We showed that E...
Prognosis for patients with estrogen-receptor (ER)-negative basal breast cancer is poor, and chemoth...
AbstractThe ubiquitin conjugating enzyme Rad6B is overexpressed in breast cancer and induces β-caten...
AbstractAutocrine Wnt signaling in the mouse mammary tumor virus model was the first identified mech...
Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation, proli...
Human breast cancer displays nuclear accumulation of β-catenin and induction of cyclin D1 expression...
Our previous data illustrated that activation of the canonical Wnt signaling pathway was enriched in...
We have previously shown that the postreplication DNA repair gene Rad6B plays a critical role in the...
SummaryThe Wnt/β-catenin signaling pathway plays a major role in tissue homeostasis, and its dysregu...
AbstractMelanoma is the leading cause of death from skin cancer in industrialized countries. Several...
SummaryCanonical Wnt signaling critically regulates cell fate and proliferation in development and d...
AbstractMany cancers have similar aberrations in various signaling cascades with crucial roles in ce...
The development of skeletal muscle from immature precursors is partially driven by canonical WNT/β-c...
We have been investigating a novel link between two independent processes linked to breast cancer: W...
Ubiquitin-specific protease 6 (USP6) is a deubiquitylase that is overexpressed by chromosome translo...
AbstractThe present study investigated the roles of E6 and E6AP in the Wnt pathway. We showed that E...
Prognosis for patients with estrogen-receptor (ER)-negative basal breast cancer is poor, and chemoth...